Search company, investor...


Founded Year




Total Raised


Date of IPO


About Aiforia

Aiforia’s AI and image analysis software equips pathologists and scientists in preclinical, academic, and clinical labs with cloud-based technology to advance their image analysis tasks and workflows.

Headquarters Location

Biomedicum 2 U Tukholmankatu 8

Helsinki, 00290,


+358 20 734 9130

Aiforia's Product Videos

Compete with Aiforia?

Ensure that your company and products are accurately represented on our platform.

Aiforia's Products & Differentiators

    Aiforia Clinical Suites

    The Aiforia Clinical Suite provides pathologists with the tools they need to not only accelerate sample review and to substantially increase productivity, but to also improve diagnostic accuracy to ultimately save more lives. with the power of AI.

Expert Collections containing Aiforia

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Aiforia is included in 5 Expert Collections, including Digital Health.


Digital Health

21,956 items

Startups recreating how healthcare is delivered


Artificial Intelligence

9,442 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.


Medical Devices

8,802 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health Monitoring & Diagnostics

2,845 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Health IT

8,264 items

Aiforia Patents

Aiforia has filed 1 patent.

The 3 most popular patent topics include:

  • Image processing
  • Color depths
  • Computing output devices
patents chart

Application Date

Grant Date


Related Topics




Image processing, Microscopy, Computing output devices, Color depths, Pathology


Application Date


Grant Date



Related Topics

Image processing, Microscopy, Computing output devices, Color depths, Pathology



Latest Aiforia News

Change in Aiforia Technologies Plc’s Management Team

Nov 24, 2022

Aiforia Technologies Oyj Thu, Nov 24, 2022 07:00 CET Aiforia Technologies Plc, Company release, 24 November 2022 at 08:00 a.m. EEST. Kari Pitkänen, Director of Business Development at Aiforia Technologies Plc, will retire by the end of December 2022. Kari is one of the founders of the company and has been a member of the Management Team since 2013. After his retirement, he will continue as a member of Aiforia’s Advisory Board. “I would like to warmly thank Kari for his significant contribution in building Aiforia from a startup to an internationally operating listed company. His fantastic career is all about developing global businesses in the fields of biotechnology and health technology. I am pleased to know that Kari will join our Advisory Board, giving us the opportunity to keep working together and to count on his support,” says Jukka Tapaninen, CEO of Aiforia Technologies Plc. As of 1 January 2023, the composition of Aiforia’s Management Team is as follows: Jukka Tapaninen, Chief Executive Officer Kaisa Helminen, Chief Operating Officer Veli-Matti Parkkonen, Chief Financial Officer Tuomas Ropponen, Chief Technology Officer Thomas Westerling-Bui, Chief Commercial Officer, Americas More detailed information on the members of the Management Team is available on the company's website at .

Aiforia Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Aiforia Rank

Aiforia Frequently Asked Questions (FAQ)

  • When was Aiforia founded?

    Aiforia was founded in 2013.

  • Where is Aiforia's headquarters?

    Aiforia's headquarters is located at Biomedicum 2 U, Helsinki.

  • What is Aiforia's latest funding round?

    Aiforia's latest funding round is IPO.

  • How much did Aiforia raise?

    Aiforia raised a total of $25.37M.

  • Who are the investors of Aiforia?

    Investors of Aiforia include PHC Holdings, Aktia Bank, Horizon 2020, Ascend Capital Partners, Tekes and 4 more.

  • Who are Aiforia's competitors?

    Competitors of Aiforia include Ibex Medical Analytics, Butterfly Network, Koios Medical, Cleerly, Lunit, Citeline, Aidoc Medical, Proscia, Deciphex, and 35 more.

  • What products does Aiforia offer?

    Aiforia's products include Aiforia Clinical Suites and 1 more.

  • Who are Aiforia's customers?

    Customers of Aiforia include Mayo Clinic and Boehringer Ingelheim .

Compare Aiforia to Competitors


Paige delivers AI-powered digital diagnostics and biomarkers for pathologists, oncologists, and the R&D community worldwide, while also working closely with biopharma companies to create custom diagnostic solutions and drug development technologies to improve patient care. The firm's target customers include pathologists, hospital leads/chairs as well as life sciences research and translational teams.

Ibex Medical Analytics Logo
Ibex Medical Analytics

Ibex Medical Analytics develops clinical decision support tools that help pathologists deliver metric-driven, objective and accurate diagnoses. It develops a diagnostic system that uses computer vision, machine learning, and electronic medical records to help confirm cancer diagnoses of tissue biopsies. The company was founded in 2016 and is based in Tel Aviv, Israel.

PathAI Logo

PathAI provides AI-powered research tools and services for pathology. PathAI's platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine and deep learning. PathAI was founded in 2016 and is based in Boston, Massachusetts.


Quibim, a company with its headquarters in Valencia, Spain, provides a whole-body medical imaging analysis. Quibim products are used worldwide by a huge diversity of research and care teams. Partners use Quibim Precision, a CE-marked whole-body imaging ecosystem, for a wide range of applications from detecting a disease to tracking the efficacy of treatments. Quibim follows an AI-first approach to help detect pathologies across every body part and imaging modality, using quantitative imaging biomarkers.

Ultrasight Logo

Ultrasight develops an automated ultrasound solution that provides AI-based navigation, analysis, and diagnosis at the point of care.

Imagen Technologies

Imagen is building a world without diagnostic errors. The company is beginning by applying the latest advances in computer vision and machine learning to medical imaging. Imagen Technologies is putting leading medical expertise in the hands of healthcare providers everywhere.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.